Like any good underdog story, ours started with an industry that said “no way.” We, of course, are delighted to prove them wrong.
When we looked at the landscape of available treatment options, we realized that patients were being asked to make too many compromises. So we set out to create a system that was not only more efficient, more convenient, and more aesthetically pleasing, it would also allow patients to see results as quickly as they appeared.
Using advanced technology and calling on the talents of a diverse team of orthodontists, bone biologists, computer scientists, engineers, and designers, InBrace is helping people everywhere reclaim their self-confidence every day.
We aren’t here to repeat what’s already been said. We’re here to change the face of orthodontics – one mouth at a time. We’re revolutionizing orthodontic technology, transforming not only how teeth are adjusted, but the entire patient experience.
How it works. How it feels. How it looks. Starting from day one. Because everyone deserves to feel confident sharing their truest selves with the world.
Patients and orthodontists trust us—and we take that very seriously. We believe in holding ourselves, our product, and our process to the highest possible levels of integrity. That is the only way that we can continue to impact the lives of millions in a healthy way.
We aren’t afraid to speak up and challenge the status quo. In fact, that’s been our MO from the start. We thrive on new perspectives and discard tired solutions. We welcome big thinkers and have no time for naysayers.
While a great idea may originate from one person, it takes an entire team of talented people to bring it to life. It is only through thoughtful, meaningful collaboration that we can create a technology that is both uniquely powerful and transformative.
Accomplished management team with deep
IPO, M&A, and category creation experience Leadership Team
John Pham DDS, MS is an entrepreneur, team builder, former aerospace engineer, and practicing orthodontist. As CEO and Co-Founder of InBrace, Dr. Pham is using his leaderships skills and treatment innovations developed from years of research to disrupt the orthodontic industry with an invisible, consumer-friendly solution for today’s active patient. He is responsible for infusing his passion for patient centered care into the company’s DNA and turning his belief in a diverse and empowered workforce into motivation for all to contribute and be successful.
Dr. John Pham is uniquely positioned to turn technology breakthroughs into success for InBrace. Dr. Pham has launched multiple start-up ventures and brings valuable, real-world experience in advanced orthodontic methods, practice development, healthcare software systems, lean manufacturing, systems management, and sales team leadership.
Dr. Pham concurrently acts as managing orthodontist for Bristol Dental and Orthodontics and Co-Principal Investigator at USC’s Advanced Orthodontics and Viterbi Engineering group. Prior to forming InBrace, Dr. Pham was co-founder of Simplifeye, a healthcare business management solution, where he focused on strategic partnerships and business development. As an aircraft engineer for Boeing Commercial Airplanes, Dr. Pham acted as Boeing’s corporate subject matter expert and primary liaison to the FAA on aircraft safety certification. Dr. Pham received his Bachelor’s degree in Engineering and Doctorate degree in Dental Surgery from UCLA and his Master’s degree in Craniofacial Biology and Residency in Orthodontics from USC.
Dr. Hongsheng Tong DDS, PhD is a highly respected orthodontic scientist, researcher and inventor; clinical assistant professor at the USC Ostrow School of Dentistry; owner of two orthodontic practices in Southern California; Diplomat of the American Board of Orthodontists; and inventor of InBrace. He has treated nearly 10,000 patients and performed extensive research on the biomechanics of tooth movement, giving Dr. Tong rare insights into the value technology can bring to personalized patient care. As Co-Founder & Principal Orthodontic Scientist at InBrace, Dr. Tong is responsible for technology innovation and advanced clinical development.
Early in his career, Dr. Tong became fascinated by the intricate biomechanics in various orthodontic treatments that drive tooth movement. He pursued his fascination of healthier, more effective orthodontics as a researcher and assistant professor at the University of Southern California, where his PhD in Craniofacial Biology brought a unique perspective to orthodontic biomechanics. Dr. Tong’s research has been published in a wide variety of cover stories and prominent articles in the American Journal of Orthodontics and Dentofacial Orthopedics and the Journal of Clinical Orthodontics. He remains a frequent lecturer at numerous advanced orthodontic programs and conferences in the United States and Asia.
Jeff Nardoci is a passionate visionary who brings extensive experience in scaling companies for global expansions, talent empowerment, mergers & acquisitions, and commercial strategy in highly competitive markets.
Jeff brings more than 25 years of experience in leadership roles specializing in healthcare, medical device, and FMG with multinational corporations and industry leaders. Prior to joining InBrace, Jeff was Chief Operating Officer at HydraFacial, where he led the global commercialization efforts and expanded the multimillion-dollar aesthetic device company to a $1B exit (NASDAQ: SKIN). His remarkable influence includes roles at Syneron-Candela, Banner Health, Solta Medical, Bausch & Lomb, and Nabisco Brands.
Kevin J. Cousins, CPA (inactive) is a seasoned, executive leader with an extensive background in life sciences and deep operational and financial experience with publicly traded companies, venture-backed startups and certified public accounting. As CFO of InBrace, Mr. Cousins will guide the company’s rapid expansion, leveraging his life sciences industry experience to ensure compliance while maximizing corporate financial performance. He is responsible for business planning, investor relations and board of director relationships, while managing the continued buildout of finance, accounting and HR infrastructures.
Mr. Cousins brings an ideal combination of business acumen, unquestionable integrity, leadership and financial skills to InBrace. He is an expert in process analysis and implementation; financial planning, budgeting and analysis; systems implementation; risk assessment and mitigation; investor relations, fund raising and venture financing; initial public offerings; mergers and acquisitions; and tax law.
Before joining InBrace, Mr. Cousins spent more than 30 years in senior executive leadership positions primarily in the life sciences industry acting as CFO. During this period, Mr. Cousins played a key role in a variety of financial transactions, initial public offerings and mergers & acquisitions totaling in excess of $1 billion. These companies include Biopsys Medical (acquired by Johnson & Johnson), Senorx (acquired by CR Bard), Neomend (acquired by CR Bard), Sequent Medical (acquired by Microvention/Terumo and Focal Therapeutics (acquired by Hologic).
Mr. Cousins began his career in public accounting with KPMG (Peat Marwick). He received his Master’s in Taxation from Golden State University and his Bachelor’s in Business Administration with an emphasis in Accounting from California State University, Fullerton.
Kenny Chang is an entrepreneur, CPA, former educator and operationally focused executive, who enjoys diving into the details to further business results. In his new role as Senior Vice President of Enterprise Development for InBrace, Mr. Chang is focused on developing company-wide strategic plans and scaling business operations to ensure operational efficiency. He is responsible for collaborating with leadership on identifying cross-functional opportunities and implementing business process improvements to achieve corporate goals.
Prior to InBrace, Kenny was in investment management, working in various aspects of fund administration for two of the largest mutual fund shops in the industry, the Capital Group and PIMCO. At PIMCO, Kenny expanded his skillset beyond traditional finance and accounting into cross-departmental team management and project development. As part of the Trade Floor Support team, he developed proprietary modeling applications by collaborating with key stakeholders throughout the organization, including portfolio management, tax, product, accounting and technology.
A die-hard Bruin, Kenny received both his Master’s in Education and BS from the University of California, Los Angeles.
As the VP of Software for InBrace, Mr. Guenterberg brings a successful track record in the design, development, and implementation of mission-critical software systems that meet the rapidly evolving needs of early stage startups. He is responsible for taking InBrace’s customer experience to the next level through software strategy, custom systems design and integration. Concurrently, Mr. Guenterberg will lead the development of simulation and machine learning systems that maximizes the performance of patented InBrace Smartwire technology.
Prior to InBrace, Mr. Guenterberg was vice president R&D at SoftWear Automation, where he led teams developing machine vision-based feedback and robotic control systems to improve sewing accuracy, robot-assisted vision localization and calibration technology and vision simulation software. While CIO and chief software architect for ClearCorrect, the second largest clear aligner company in the world, he significantly reduced treatment planning and manufacturing costs through a full dental CAD/CAM suite developed in-house that included custom orthodontic workflows, interactive treatment planning systems, 3D modeling segmentation software, and manufacturing systems control. Mr. Guenterberg was also CTO and Co-Owner of MadPad Mobile and Developer at Air Strategy, LLC.
As Head of InSights & InNovation, Mr. Oda is developing the next category of breakthrough products in the orthodontic industry.
Mr. Oda spent 12 years at Ormco (orthodontic division of Danaher, NYSE: DHR, +$170B Mkt Cap) leading the development of the most successful orthodontic braces product in the world, The Damon System. Mr. Oda spent the next 5 years at 3M where he brought to market numerous new orthodontic systems. Mr. Oda’s specialty is developing and scaling innovations that solve business problems by focusing on intuitive design.
In addition to orthodontics, Mr. Oda spent 10 years in the semiconductor industry developing complex underwater welding systems.
Clint has served as Chief Executive Officer for The HydraFacial Company since December 2016, bringing a broad and deep experience in non-invasive aesthetics and skin health. Clint championed the rebranding of the company in 2017 and drove the company strategy and culture shift that has resulted in explosive revenue growth and rapidly growing global recognition. HydraFacial’s success was recently validated in a successful public offering and renamed BeautyHealth (NASDAD: SKIN).
Previous to HydraFacial, Clint founded and later successfully sold Charleston Renal Care, a chain of dialysis centers to DaVita. He was instrumental in the development of LASIK during the early 2000’s as head of surgical for Bausch + Lomb, contributing to the rapid growth of corporate refractive chains. Clint brought his skills to non-invasive aesthetics, joining Thermage in 2005 where he was Chief Operating Officer and helped take the company public in 2006. Later named Solta Medical, the brands Thermage, Fraxel and Clear + Brilliant are still globally recognized by consumers and physicians alike. He is also Chairman of OrangeTwist Brands.
As the former president of both American Orthodontics Corporation and 3M Unitek (orthodontic division of 3M, NYSE:MMM, $117.74B Market Cap), Rich Iverson is an ideal consultant, strategic business advisor, and mentor to the InBrace executive team. Mr. Iverson is leveraging his extensive leadership skills and experience to support the executive team in building a strong scalable foundation for operational and customer support excellence.
Dr. Ron Redmond is globally recognized expert in orthodontic practice performance and has been at the nexus of each wave of technology that has hit orthodontics over the last 40 years. As a Board Member of Swift Health Systems, Dr. Redmond helps the executive team navigate the barriers to new technology adoption with a data centric approach toward improving practice performance. Within the close knit orthodontic community, Dr. Redmond’s name is synonymous with innovation.
Dr. Redmond has served in many leadership capacities, most notably as CEO of the Schulman Study Group, an internationally recognized organization of practice performance experts, from 2003 to 2017. The Schulman Study Group’s invitation only membership are exclusively in the top 1% highest grossing private practices across the country. He speaks regularly at the annual meetings of national and regional orthodontic associations.
Dr. Redmond also served as Associate Editor of the Journal of Clinical Orthodontics, and previously owned practices in multiple locations in Orange County, California and Seattle, Washington. Dr. Redmond is an Associate Professor of Orthodontics at the Dugoni School of Dentistry, San Francisco and sat on the Board of Regents of the University of the Pacific for 11 years.
Dan Ellis has been an advisory board member since 2020. Dan was VP of North American Sales for Align Technologies (NYSE: ALGN, +$40B Mkt Cap) in the early stages where he helped grow the company from less than $150M to almost $600M in revenue.
Dan began his career as a sales person at Physio Control, a part of Eli Lily’s medical device and diagnostics division. Subsequently, he rose to positions of increased leadership and responsibility in the division and at Guidant, once the division was spun out.
He found his calling in early stage organizations and had stops at Fusion Medical, Cardiac Pathways, and Barrett Medical along the way. Now retired, Dan spends his time helping early stage companies grow and mentoring students. Dan is a business graduate of Oregon State University and served as an infantry office in the US Marine Corps.
Eddie Yoon is the founder of EddieWouldGrow, LLC, a think tank and growth strategy firm working exclusively with Category Creators. His work has helped clients generate $10B+ in annual revenue and much more in incremental market capitalization. He focuses on VC and PE backed companies seeking to maximize their valuation, and includes two recent $1B+ unicorns. Prior to this, Eddie was a senior partner at The Cambridge Group, a growth strategy firm that was acquired by Nielsen.
He is also the co-founder of Category Pirates, a substack newsletter that is the definitive authority on Category Design/Creation. His co-founders are Christopher Lochhead, 3x Silicon Valley CMO, author of Play Bigger and host of the Top 100 iTunes podcast Follow Your Different, and Nicolas Cole, founder of Digital Press, and viral writer with more than 100 million views who has written on behalf of 300 different founders, executives and venture capitalists.
He is the author of the book Superconsumers, published by the Harvard Business Press, and more than 70+ articles on growth and category creation on HBR. He has been cited in the Wall Street Journal, New York Times, The Economist, Bloomberg Businessweek and has appeared numerous times on CNBC and MSNBC. He is a graduate of the University of Chicago.
Dr. Glenn T. Sameshima DDS PhD is Chairman and Program Director of the Advanced Orthodontic Program at the Herman Ostrow School of Dentistry of the University of Southern California, Los Angeles, California, USA, where he holds the rank of associate professor with tenure.
Glenn is recognized worldwide as an authority on orthodontic root resorption, and his current research interests include digital orthodontics, retention and stability, non-cooperation appliances, impacted teeth, and investigating treatment claims.
He received his BS in mathematics from UCLA, and DDS from UC San Francisco. His certificate in Orthodontics, and PhD in Craniofacial Biology were earned from USC. A Diplomate of the American Board of Orthodontics, he is also the graduate orthodontic clinic director at USC. He has served on the PCSO Board of Directors, been appointed a Consultant to the ADA Committee on Accreditation, and is currently the PCSO representative to the AAO Council on Education. Dr. Sameshima is an active clinician with over 30 years experience in private practice in Torrance, California.
Dr. John J. Tracy served as Boeing’s Chief Technology Officer and Senior Vice President of Engineering, Operations, and Technology from 2006 through his retirement in 2016. In this role, he reported to the Boeing Chairman and CEO and served on the company’s Executive Council. Upon retirement from Boeing after 35 years, Dr. Tracy was leading more than 100,000 employees across several functional and business organizations and had responsibility for Engineering, Operations, Global Supply Chain, and Intellectual Property Management.
Dr. Tracy currently sits on the board of directors for 3D Systems, a world leader in 3D digital manufacturing technology. As Senior Executive Advisor, Dr. Tracy’s impressive depth and breadth of experience is incredibly valuable for guiding Swift Health Systems through the large and complex challenges of scaling an operational infrastructure for global distribution.
Dr. Tracy received a PhD in Engineering from the University of California, Irvine, and a master’s degree in Physics from California State University, Los Angeles and a bachelor’s degree in Physics from California State University, Dominguez Hills.
Dr. Marc Lemchen is widely recognized as one of the most entrepreneurial and innovative minds in orthodontics. In addition to his prestigious private orthodontic practice in New York City, Marc was a pioneer in digital dentistry as the founder of Dolphin Imaging Systems and developer of Dolphin Management Program (practice management program). In addition, he has been on the development task force for a number of state-of-the-art orthodontic appliance systems and is the holder of numerous patents in a variety of fields.
Dr. Lemchen sits on the Board of Advisors of Tufts University School of Dental Medicine and is Adjunct Assistant Professor at Tufts University School of Dental Medicine.
Nancy Stagliano PhD is an accomplished serial biotechnology entrepreneur and executive. She is currently a Venture Partner at New Leaf Venture Partners. Previously, as chief executive officer, Nancy has successfully launched and/or exited three consecutive biotech companies: CytomX Therapeutics (CTMX), iPierian and, most recently, True North Therapeutics, a New Leaf portfolio company. As chief executive officer and co-founder of True North Therapeutics, Nancy led the company to its recent acquisition by Bioverativ, Inc. for a total deal value of up to $825 million.
Previously, Nancy was chief executive officer of iPierian, Inc., which applied human iPSCs to model neurodegenerative diseases and was acquired by Bristol-Myers Squibb in April of 2014 for a total deal value of $725 million. From 2008–2010, Nancy was the chief executive officer and co-founder of CytomX Therapeutics and a lead inventor on the CytomX Probody platform. Before moving to California, Nancy worked in Cambridge, Massachusetts, where she had an eight-year tenure at Millennium Pharmaceuticals.
Nancy received her bachelor of science degree in electrical engineering and master of science degree in biomedical engineering from Drexel University in Philadelphia. She obtained her doctor of philosophy degree in neuroscience from the University of Miami, Miller School of Medicine, in Miami.
Help us bring the most most-advanced teeth-straightening system (and the one patients are asking for) to more people.
It seems impossible to put a price on finally feeling yourself, but this cost estimator will at least give you an idea of how much InBrace might cost. Remember to check with your dental insurance provider about coverage and your orthodontist about any possible payment plans.
